Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Overview of attention for article published in Blood Advances, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 37 X users

patent: 1 patent
reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 115 Mendeley

So far, Altmetric has seen 43 X posts from 37 X users, with an upper bound of 176,987 followers.

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort https://t.co/3MlDrg4SOV #HospUnivCáceres (Hematología) https://t.co/ubkqgW1cJR

RT @MikkaelSekeres: Proud to contribute to this study - the first large-scale justification for these drugs in r/r AML! https://t.co/YHnNip…

RT @BloodAdvances: Hypomethylating agents in relapsed and refractory #AML: outcomes and their predictors in a large international patient c…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 39 additional X posts.